What is Alluzience®?
Alluzience® (liquid botulinum toxin type A) is the first ready-to-use BoNT-A liquid neuromodulator formulation introduced in Europe. Designed for both medical and cosmetic applications, it provides a prolonged effect compared to other botulinum toxin products, reducing the frequency of treatments required to maintain desired results. This innovative formulation is particularly beneficial for treating chronic migraines, muscle spasticity, and certain types of muscle dystonia, offering convenience and improved quality of life for patients requiring ongoing management.
Alluzience® is a licensed product from Ipsen and a registered trademark of Ipsen. Galderma holds an exclusive license from Ipsen to develop, promote, and distribute Alluzience® for approved indications in Europe, excluding Greece, Lithuania, Estonia, Latvia, and Hungary.
How does Alluzience® work?
Alluzience® should only be administered by a physician with the necessary qualifications and expertise in this treatment, using the appropriate equipment. At Beauty Digger Clinic, our team is fully qualified to administer Alluzience®, ensuring you receive safe and effective treatment. This advancement represents a significant leap in the therapeutic use of botulinum toxin, combining efficacy with enhanced patient compliance.
Alluzience® can be used for all the areas where traditional botulinum toxin is applied, including but not limited to the upper face, gummy smile, Nefertiti neck lift, trap tox, and calves slimming.
Difference Than Other Products
Alluzience® (liquid botulinum toxin type A) distinguishes itself from other botulinum toxin products through its ready-to-use liquid formulation and prolonged duration of action. Traditional botulinum toxin products typically come in a powder form that requires reconstitution before use, which can introduce variability in concentration and efficacy. In contrast, Alluzience® is pre-mixed, ensuring consistent dosage and reducing the risk of dilution errors, thus enhancing both safety and convenience for practitioners.
Moreover, Alluzience® boasts a rapid onset of action, with effects visible in as little as 24 hours, and its benefits can last for up to six months. This sustained-release mechanism reduces the frequency of injections needed to maintain desired results, providing a significant advantage for patients seeking both cosmetic and therapeutic benefits. For instance, while many botulinum toxin products require treatments at intervals as short as every three to four months, Alluzience® often allows for longer intervals between treatments, thus improving patient compliance and satisfaction. This makes it particularly useful for managing chronic conditions like migraines and muscle spasticity, as well as for achieving long-lasting cosmetic improvements.
Side effects
As with any medical treatment, Alluzience® (liquid botulinum toxin type A) can have side effects. While many patients tolerate the treatment well, some may experience adverse effects. The most common side effects include localized pain at the injection site, swelling, redness, and bruising. These reactions are usually mild and resolve on their own within a few days.
Other potential side effects can include headache, muscle weakness, or flu-like symptoms.
Before & After Gallery
Frequently
Asked Questions
Alluzience® is used for both medical and cosmetic purposes, including treating chronic migraines, muscle spasticity, and certain types of muscle dystonia, as well as reducing the appearance of wrinkles.
Unlike traditional botulinum toxin products that come in powder form and require reconstitution, Alluzience® is a ready-to-use liquid, ensuring consistent dosage and reducing the risk of dilution errors.
It also has a quicker onset of action, with effects noticeable within 24 hours, and its benefits can last for up to six months.
Alluzience® offers a prolonged duration of effect, rapid onset of action, and convenience of use, reducing the frequency of treatments needed to maintain results.
The treatment involves injections at the targeted areas, which may cause mild discomfort, localized pain, or bruising at the injection site.
Due to its prolonged effect, treatments may be needed less frequently, typically every six months, compared to every three to four months for other botulinum toxin products.
As with many medical cosmetic treatments, it is not advisable to Alluzience while pregnant or breastfeeding. Alluzience has not been tested or verified for safety and efficacy on pregnant patients, so there is no concrete evidence to support the safety of Alluzience in this group of patients.
The effects of Alluzience® can be visible within 24 hours after treatment.
The benefits of Alluzience® can last up to six months, longer than many other botulinum toxin products.
